AstraZeneca’s Andrea Mugan shares her unique perspectives on patients, experience, change and challenges
AstraZeneca’s Andrea Mugan shares her unique perspectives on patients, experience, change and challenges
Why haven’t we been delivering more life sciences research in primary care?
The partnership paradigm in clinical research
Total-body PET imaging platform set to enhance scope of research into complex diseases and improve patient outcomes
Producing medicines must focus on materials and net-zero, but also how we work
Taking action for a sustainable supply chain
How can pharma and med device companies support the NHS with service optimisation?
Professor Gino Martini, CEO of the PHTA, on how Birmingham is boosting lab capacity
Post-pandemic, we have been forced to rethink the way in which medicines information is disseminated and consumed
When it comes to the labelling for medical purposes, highly accurate labels are essential
Kate Downey talks about changing career direction and embracing patient engagement
For the full picture ethnographic specialists Naked Eye and healthcare agency VCCP treat patients as individuals
Mapping the next generation of life sciences talent
Although each individual disease is rare, their collective prevalence is estimated at around 6%-8% of the population
Short-term fix or long-term fixture for clinical trials?